11 results
Pharmacotherapy for Migraine Prophylaxis 

Who is indicated for migraine prophylaxis? Patients who experience more than 3
indicated for migraine prophylaxis ... appropriate acute treatment ... #Medications #Table ... #Pharmacology # ... Management #Neurology
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... itraconazolea 200 mg PO BID ... Penicilliosis #IDSA ... #Prevention #Treatment ... infections #HIVAIDS #pharmacology
Summary of meta-analysis of pharmacotherapy trials in BPD
https://www.cochrane.org/CD005652/BEHAV_psychological-therapies-borderline-personality-disorder
Meta-analyses of RCTs were undertaken for the following outcomes:
symptoms, mental ... with ‘treatment ... EBM #Management #Pharmacology ... Personality #Disorder #Medications ... Effectiveness #Table
Migraine Prevention and Prophylaxis
Who to Consider: 
 • ≥ 4 significant headaches or migraine attacks/month
 •
Prevention and Prophylaxis ... acute migraine treatments ... Severe/DisabIing symptoms ... Preventative Medications ... #neurology #headache
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
IDSA Recommendations ... please refer to Table ... AviumComplex #MAC #IDSA ... #Prevention #Treatment ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Isospora belli Infection in HIV-AIDS
Treating Isospora belli Infection
General Management Considerations:
 • Fluid
IDSA Recommendations ... 3–4 weeks) if symptoms ... Therapy (Secondary Prophylaxis ... #Prevention #Treatment ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Histoplasma Capsulatum Infections in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
IDSA Recommendations ... for 3 days, then BID ... with ARV (see Table ... #Prevention #Treatment ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Prevention and Treatment of Pneumocystis Pneumonia (PCP) in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
IDSA Recommendations ... Prevention and Treatment ... daily or 50 mg PO BID ... #Prevention #Treatment ... HIVAIDS #management #pharmacology
Posterior Reversible Encephalopathy Syndrome (PRES) Overview

Clinico-Radiological Syndrome, characterized by:
 • Headache
 • Seizures
 • Altered mental
Neurological symptoms ... Electrolyte abnormality, Medication ... /Drug toxicity, ... epilepticus Treatment ... underlying cause • Treatment
Lithium Therapy for Bipolar Disorder 
Toxicity Levels: 
 - Mild (1-1.5 mEq/L) 
 - Moderate (1.6-2.5
gain Toxicity Symptoms ... Lithium is a medication ... maintenance agent for treatment ... Bipolar #Disorder #BPD ... #Toxicity #Pharmacology